Caristo Diagnostics' CaRi-Heart® Coronary Inflammation Technology Authorized by U.S. FDA

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Caristo-Diagnostics

More Like This

PR Newswire associated0

The Lancet Publishes Results from World's Largest Coronary CT Registry Showing New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation At Least 10 Years in Advance

PR Newswire associated0

Caristo to Unveil New Clinical and Research Results at SCCT 2025

Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026

PR Newswire associated0

American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI

PR Newswire associated0

Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention

PR Newswire associated0

Pioneering the Future of Heart Health: Biograph and Caristo Diagnostics Announce First-of-its-Kind U.S. Study to Advance AI-Powered Prevention

PR Newswire associated0

New Study: CaRi-Heart® Technology Highly Cost-Effective in the NHS

PR Newswire associated0

AMA Approves CPT Codes for Caristo's AI-Powered Heart Disease Risk Stratification and Prevention Technology